Showing results (51-60 of 1,128) with videos related to
Sort By:
Pageof 113
Journal of Hepatocellular Carcinoma|August 4, 2023
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching AnalysisHan Li, Ke Su, Lu Guo, et al.Journal of Hepatocellular Carcinoma|August 1, 2023
Erratum: Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses [Corrigendum]Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.Journal of Hepatocellular Carcinoma|August 17, 2023
Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP ScoreBaocuo Gong, Xuewen Wang, Wanting Guo, et al.Journal of Hepatocellular Carcinoma|August 15, 2023
Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive MicroenvironmentDehai Wu, Guanqun Liao, Yuanfei Yao, et al.Journal of Hepatocellular Carcinoma|October 27, 2023
Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial ChemoembolizationQin Shi, Peng Huang, Zihan Zhang, et al.Journal of Hepatocellular Carcinoma|October 16, 2023
Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune MicroenvironmentRenhou Zhi, Pengfei Hao, Weibin Li, et al.Journal of Hepatocellular Carcinoma|October 11, 2023
Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic ReviewsJingxin Yan, Yonghao Wen, Manjun Deng, et al.Journal of Hepatocellular Carcinoma|October 11, 2023
Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular CarcinomaBingran Yu, Ning Zhang, Yun Feng, et al.Journal of Hepatocellular Carcinoma|October 12, 2023
Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular CarcinomaBingran Yu, Ning Zhang, Yun Feng, et al.Pageof 113